PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Shenzhen Zesum Technology
301486
4
Henan Shijia Photons Technology
688313
5
Hanjia Design Group
300746
CN Stock MarketDetailed Quotes
301047 Sino Biological Inc.
- 61.18
- -0.19-0.31%
Trading Apr 25 13:56 CST
7.44BMarket Cap73.80P/E (TTM)
61.65High60.80Low3.32KlotVolume61.48Open61.37Pre Close20.32MTurnover0.28%Turnover Ratio61.06P/E (Static)121.64MShares87.8252wk High1.29P/B7.32BFloat Cap53.5152wk Low73.64Limit Up119.58MShs Float358.85Historical High49.10Limit Down1.39%Amplitude53.51Historical Low2.00Dividend TTM61.16Avg Price1.81KlotAsk3.27%Div YieldTTM100Lot Size1.34KlotBid
Sino Biological Inc. Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.94%155.3M | -5.06%613.67M | -2.33%464.95M | 4.54%305.66M | -3.02%152.35M | 12.49%646.39M | 10.64%476.06M | -2.31%292.38M | -10.67%157.09M | -40.47%574.6M |
| Operating revenue | 1.94%155.3M | -5.06%613.67M | -2.33%464.95M | 4.54%305.66M | -3.02%152.35M | 12.49%646.39M | 10.64%476.06M | -2.31%292.38M | -10.67%157.09M | -40.47%574.6M |
| Other operating revenue | ---- | 70.84%26.38M | ---- | 735.66%13.7M | ---- | --15.44M | ---- | --1.64M | ---- | --0 |
| Total operating cost | 20.24%147.35M | 25.17%557.64M | 32.43%412.23M | 36.51%266.74M | 21.65%122.55M | 52.56%445.51M | 57.51%311.28M | 63.91%195.4M | 53.90%100.74M | 17.02%292.03M |
| Operating cost | 23.93%40.18M | 41.34%163.92M | 33.37%118.95M | 35.53%80.98M | 46.97%32.42M | 34.80%115.98M | 49.07%89.19M | 67.23%59.75M | 23.57%22.06M | 47.73%86.04M |
| Operating tax surcharges | 2,646.86%1.49M | 45.74%9.42M | 596.40%4.6M | 658.04%4.46M | -97.10%54.22K | -23.42%6.47M | -87.61%660.56K | -84.93%588.64K | -5.53%1.87M | -37.38%8.44M |
| Operating expense | 8.32%41.33M | 1.32%156.05M | 4.67%117.66M | -0.01%75.63M | 6.87%38.15M | 24.28%154.01M | 23.43%112.41M | 33.08%75.64M | 22.46%35.7M | 52.14%123.93M |
| Administration expense | 9.98%37.83M | 18.14%149.14M | 22.89%110.41M | 25.72%71.03M | 41.45%34.4M | 51.44%126.25M | 44.04%89.84M | 46.81%56.5M | 32.25%24.32M | 38.88%83.37M |
| Financial expense | 125.23%1.76M | 72.89%-12.1M | 86.09%-5.82M | 78.94%-7.46M | -1.47%-6.98M | 36.13%-44.64M | 30.59%-41.86M | 9.63%-35.43M | 47.12%-6.88M | -1,746.86%-69.89M |
| -Interest expense (Financial expense) | -17.71%852.72K | 6.64%3.98M | 29.83%3.03M | 20.96%1.94M | 25.01%1.04M | 34.46%3.73M | 18.12%2.33M | 22.50%1.61M | 31.43%828.91K | 37.89%2.77M |
| -Interest Income (Financial expense) | 82.78%-1.26M | 61.03%-18.29M | 56.41%-16.46M | 51.25%-12.18M | 40.62%-7.32M | 22.99%-46.94M | 22.43%-37.76M | 25.20%-24.99M | 19.50%-12.32M | -323.36%-60.96M |
| Research and development | 1.06%24.76M | 4.30%91.21M | 8.84%66.43M | 9.75%42.09M | 3.52%24.5M | 45.39%87.45M | 55.18%61.04M | 63.47%38.35M | 113.30%23.67M | 49.88%60.15M |
| Credit Impairment Loss | 156.92%1.3M | 25.41%-8.26M | -11.40%-5.39M | 7.47%-2.68M | 0.89%-2.29M | -3,341.78%-11.08M | -1,679.20%-4.84M | -379.75%-2.9M | -686.98%-2.31M | 93.25%-321.87K |
| Asset Impairment Loss | -102.72%-2.84M | 28.41%-7.07M | 13.58%-5.33M | 26.53%-2.61M | 24.52%-1.4M | -10.05%-9.87M | 9.74%-6.16M | 5.81%-3.56M | -421.53%-1.86M | 16.45%-8.97M |
| Other net revenue | -35.75%15.26M | -2.03%85.3M | -6.47%65.27M | -15.29%48.96M | -33.70%23.76M | 45.27%87.07M | -22.04%69.78M | 32.23%57.8M | 48.26%35.83M | -52.41%59.94M |
| Fair value change income | -113.69%-848.66K | -55.52%4.88M | -52.31%5.03M | -37.86%7.26M | -52.29%6.2M | 176.33%10.98M | 218.73%10.54M | 140.57%11.68M | 163.50%12.99M | -142.13%-14.38M |
| Invest income | -18.51%16.02M | -4.51%85.31M | -4.00%63.45M | -9.76%44.42M | -19.40%19.66M | 30.36%89.34M | -27.76%66.1M | -34.07%49.23M | -44.83%24.39M | 70.56%68.54M |
| Asset deal income | 62.30%-120.35K | -781.52%-354.21K | -183.10%-315.07K | -1,035.64%-319.27K | -1,028.34%-319.27K | -75.70%51.97K | 550.73%379.15K | --34.12K | --34.39K | 2,746.84%213.85K |
| Other revenue | -8.37%1.75M | 41.12%10.79M | 107.87%7.82M | -12.69%2.89M | -26.14%1.91M | -48.54%7.65M | -72.98%3.76M | 491.21%3.31M | 577.28%2.59M | -77.87%14.86M |
| Operating profit | -56.66%23.21M | -50.92%141.33M | -49.70%117.99M | -43.22%87.88M | -41.90%53.56M | -15.93%287.95M | -27.19%234.56M | -30.84%154.78M | -31.49%92.18M | -59.31%342.51M |
| Add:Non operating Income | ---- | ---- | ---- | ---- | ---- | -94.69%1.27K | -94.69%1.27K | --1.27K | --1.27K | -99.53%23.95K |
| Less:Non operating expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.44%20.84K |
| Total profit | -56.66%23.21M | -50.92%141.33M | -49.70%117.99M | -43.22%87.88M | -41.90%53.56M | -15.93%287.95M | -27.20%234.56M | -30.84%154.78M | -31.49%92.18M | -59.49%342.51M |
| Less:Income tax cost | -94.11%577.44K | -30.24%19.41M | -36.41%18.67M | -11.40%16.94M | 15.42%9.8M | -29.68%27.82M | -36.56%29.37M | -39.50%19.12M | -58.21%8.49M | -68.47%39.55M |
| Net profit | -48.27%22.64M | -53.13%121.93M | -51.60%99.32M | -47.71%70.94M | -47.71%43.76M | -14.14%260.13M | -25.63%205.2M | -29.42%135.66M | -26.74%83.7M | -57.92%302.96M |
| Net profit from continuing operation | -48.27%22.64M | -53.13%121.93M | -51.60%99.32M | -47.71%70.94M | -47.71%43.76M | -14.14%260.13M | -25.63%205.2M | -29.42%135.66M | -26.74%83.7M | -57.92%302.96M |
| Net profit of parent company owners | -48.27%22.64M | -53.13%121.93M | -51.60%99.32M | -47.71%70.94M | -47.71%43.76M | -14.14%260.13M | -25.63%205.2M | -29.42%135.66M | -26.74%83.7M | -57.92%302.96M |
| Earning per share | ||||||||||
| Basic earning per share | -45.07%0.1861 | -52.67%0.953 | -50.97%0.7787 | -47.37%0.5526 | -47.70%0.3388 | -24.31%2.0134 | -37.37%1.5882 | -46.13%1.05 | -61.44%0.6478 | -79.07%2.6599 |
| Other composite income | -181.84%-4.94M | -44.42%-9.45M | 72.04%-2.55M | 116.53%2.55M | 381.24%6.04M | 13.88%-6.54M | 11.96%-9.12M | -248.28%-15.44M | -123.88%-2.15M | -236.62%-7.6M |
| Other composite income of parent company owners | -181.84%-4.94M | -44.42%-9.45M | 72.04%-2.55M | 116.53%2.55M | 381.24%6.04M | 13.88%-6.54M | 11.96%-9.12M | -248.28%-15.44M | -123.88%-2.15M | -236.62%-7.6M |
| Total composite income | -64.47%17.69M | -55.65%112.48M | -50.65%96.77M | -38.87%73.49M | -38.93%49.8M | -14.14%253.59M | -26.16%196.08M | -35.97%120.22M | -28.02%81.55M | -59.29%295.36M |
| Total composite income of parent company owners | -64.47%17.69M | -55.65%112.48M | -50.65%96.77M | -38.87%73.49M | -38.93%49.8M | -14.14%253.59M | -26.16%196.08M | -35.97%120.22M | -28.02%81.55M | -59.29%295.36M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.